Edition:
United Kingdom

Intra-Cellular Therapies Inc (ITCI.OQ)

ITCI.OQ on NASDAQ Stock Exchange Global Select Market

15.24USD
15 Dec 2017
Change (% chg)

$0.34 (+2.28%)
Prev Close
$14.90
Open
$15.08
Day's High
$15.48
Day's Low
$14.96
Volume
927,434
Avg. Vol
257,431
52-wk High
$22.65
52-wk Low
$7.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.03 -0.527
Jun '17 0.11 -0.409
Mar '17 0.10 -0.621
FY 2016 Dec '16 0.10 -0.635
Sep '16 0.00 -0.700
Jun '16 0.23 -0.713
Mar '16 0.00 -0.645
FY 2015 Dec '15 0.03 -0.669
Sep '15 0.00 -0.911
Jun '15 0.06 -0.615
Mar '15 0.00 -0.724
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 6 0.07 0.10 0.00 0.00
Quarter Ending Mar-18 4 0.03 0.10 0.00 --
Year Ending Dec-17 6 0.29 0.40 0.20 0.03
Year Ending Dec-18 8 0.10 0.42 0.00 0.05
Earnings (per share)
Quarter Ending Dec-17 7 -0.53 -0.45 -0.64 -0.91
Quarter Ending Mar-18 4 -0.52 -0.46 -0.60 --
Year Ending Dec-17 7 -2.08 -1.96 -2.22 -3.21
Year Ending Dec-18 9 -2.64 -1.94 -4.53 -3.49
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.66 32.93
P/E High - Last 5 Yrs. -- 290.77 45.62
P/E Low - Last 5 Yrs. -- 93.67 24.34
Beta 0.75 0.85 0.88
Price to Sales (TTM) 2,803.96 100.68 5.40
Price to Book (MRQ) 2.11 13.50 5.38
Price to Tangible Book (MRQ) 2.58 13.43 6.78
Price to Cash Flow (TTM) -- 76.24 23.45
% Owned Institutions -- 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -49.77 433.88 9.00
Sales (TTM) vs TTM 1 Yr. Ago 20.52 75.04 5.38
Sales - 5 Yr. Growth Rate -57.32 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 42.64 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago 19.48 -- --
EPS - 5 Yr. Growth Rate -- 43.18 10.79
Capital Spending - 5 Yr. Growth Rate 22.39 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 50.10 5.36 2.98
LT Debt to Equity (MRQ) 0.00 18.93 11.56
Total Debt to Equity (MRQ) 0.00 20.59 15.81
Interest Coverage (TTM) -- -111.94 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -33,426.53 -- --
EBITD - 5 Yr. Avg -4,337.35 -261.13 15.24
Operating Margin (TTM) -33,491.20 -556.69 7.76
Operating Margin - 5 Yr. Avg. -4,343.66 -279.31 10.75
Pre-Tax Margin (TTM) -32,462.57 -529.93 8.57
Pre-Tax Margin - 5 Yr. Avg. -4,292.90 -279.05 11.17
Net Profit Margin (TTM) -32,804.33 -531.37 4.88
Net Profit Margin - 5 Yr. Avg. -4,309.23 -282.22 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 7,617 25,316,769 864,680,848
Net Income/Employee (TTM) -2,498,650 3,332,346 101,718,394
Receivable Turnover (TTM) 3.90 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.00 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -25.70 -0.77 11.00
Return on Assets - 5 Yr. Avg. -33.57 -0.26 12.43
Return on Investment (TTM) -26.58 2.36 14.46
Return on Investment - 5 Yr. Avg. -34.92 2.98 16.28
Return on Equity (TTM) -26.76 2.96 16.05
Return on Equity - 5 Yr. Avg. -35.69 6.41 17.51
  1 Year 3 Year 5 Year
Sales % 261.97 -50.56 -57.32
EPS (TTM) % 7.32 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Intra-Cellular Therapies Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -22.91 -25.57 7 53
13 Week 34.61 28.06 86 60
26 Week 16.70 7.83 72 69
52 Week 11.19 -5.75 60 46
YTD 9.28 -4.03 53 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 83.33%
# of Holders: 197
Total Shares Held: 45,478,378
3 Mo. Net Change: 9,906,252
# New Positions: 51
# Closed Positions: 12
# Increased Positions: 104
# Reduced Positions: 45
# Net Buyers: 59
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.